In 2013, Susan Klugman discovered perplexing results from a noninvasive prenatal test (NIPT) indicating a chromosomal condition in a 13-week-old fetus, contradicting its healthy ultrasound image. Following the birth, the mother tragically passed away from renal cancer, leading Klugman to ponder a possible connection. While NIPT minimizes the risks associated with invasive testing, its wider adoption has resulted in an increased incidence of false positives and missed diagnoses. Despite these challenges, NIPT's accuracy and ease of access have made it popular, being used extensively across the globe with substantial market growth.
Klugman's inquiry into unexpected prenatal test results led her to consider links between false positives in NIPT and unrelated health issues like renal cancer, raising essential questions.
NIPT is a game changer in prenatal testing, allowing safer and more accurate assessment of chromosomal conditions. However, it is not without its own complications.
Collection
[
|
...
]